Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, SARS-CoV-2 test
Clinical narrative: my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; It is really impacting my daily life.; Dose 1, Drug Start date: 21Aug2021/ Dose 2, Drug Start date: 11Nov2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Nov2021 14:45 (Lot number: 33026BD) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ADVAIR HFA; ALBUTEROL SULFATE; OXYCODONE. Vaccination history included: Bnt162b2 (Previous dose product:COVID 19, Previous dose brand:Pfizer, Previous dose lot number: EW0183,, Prev dose administration date:21Aug2021 , Previous dose administration time: 16:00, Previous dose number:1, Previous dose vaccine location:Left arm), administration date: 21Aug2021, when the patient was 37 years old, for Covid-19 immunization, reaction(s): "joint pain", "moderate swelling in both hands". The following information was reported: PERIPHERAL SWELLING (disability), PAIN (disability), ARTHRALGIA (disability), PAIN IN EXTREMITY (disability) all with onset 12Nov2021, outcome "unknown" and all described as "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (disability) with onset 12Nov2021, outcome "unknown", described as "It is really impacting my daily life."; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 11Nov2021 14:45, outcome "unknown", described as "Dose 1, Drug Start date: 21Aug2021/ Dose 2, Drug Start date: 11Nov2021". The events "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms", "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms", "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms" and "it is really impacting my daily life." were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Dec2021) positive, notes: Nasal Swab Unknown (done at "PRIVACY"); (07Jan2022) positive, notes: Nasal Swab Unknown (done at Urgent care). Therapeutic measures were not taken as a result of peripheral swelling, pain, arthralgia, pain in extremity, loss of personal independence in daily activities.  Clinical course: The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. He had never experienced or deal with anything like this until he received the vaccines.  No follow-up attempts are possible. No further information is expected.